Effects of recombinant tumour necrosis factor (rTNF-alpha) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF-alpha administration in isolated limb perfusions in cancer patients

Eur J Clin Invest. 1993 Dec;23(12):812-8. doi: 10.1111/j.1365-2362.1993.tb00735.x.

Abstract

To obtain insight in the effect of TNF on the synthesis of acute phase proteins like CRP, alpha 1-antitrypsine, alpha 1-acidglycoprotein, C3 and C4 and the immunoglobulins (IgG-M-A), nine cancer patients who were treated with an isolated limb perfusion (ILP) with high dose recombinant TNF-alpha (rTNF-alpha) were investigated during a 7-day period after the end of the perfusion. Resorption of rTNF-alpha from out of these limbs into the circulation after the ILP induced within 30 min to 6 h in all patients elevated serum levels of IL-6. At the same time C-reactive protein became detectable in serum. The highest serum levels were obtained at 48 h after ILP. The serum levels of the other acute phase proteins (alpha 1-acidglycoprotein, alpha 1-antirypsine, C3, C4), rose more slowly and the highest serum levels were found at the third day. All investigated proteins declined after they had reached their peak levels. Levels of alpha 1-acidglycoprotein and alpha 1-anti-trypsin alpha 1-acid declined slower than both complement component. In regard to the immunoglobulin levels a nearly continuous increase in the serum level of specifically IgM was observed. This study clearly shows the interrelationship between TNF-alpha and IL-6 in regard to the synthesis of the different acute phase proteins; and moreover also a striking effect on IgM synthesis.

MeSH terms

  • Acute-Phase Proteins / biosynthesis*
  • Adult
  • Aged
  • C-Reactive Protein / analysis
  • Chemotherapy, Cancer, Regional Perfusion
  • Female
  • Humans
  • Immunoglobulins / biosynthesis*
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Neoplasms / metabolism*
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Acute-Phase Proteins
  • Immunoglobulins
  • Interleukin-6
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein